Cytotoxic T lymphocytes directed against donor HLA class I antigens on airway epithelial cells are present in bronchoalveolar lavage fluid from lung transplant recipients during acute rejection

被引:12
|
作者
Nakajima, J
Poindexter, NJ
Hillemeyer, PB
Trulock, EP
Cooper, JD
Patterson, GA
Mohanakumar, T
Sundaresan, RS
机构
[1] Washington Univ, Sch Med, Barnes Hosp, Div Cardiothorac Surg, St Louis, MO USA
[2] Washington Univ, Sch Med, Barnes Hosp, Dept Surg & Pathol, St Louis, MO USA
[3] Washington Univ, Sch Med, Barnes Hosp, Dept Med,Pulm & Crit Care Div, St Louis, MO USA
来源
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0022-5223(99)70336-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The lung epithelium is among the first donor tissues encountered by the lung allograft recipient's immune system. The purpose of this study was to determine whether lung epithelium was recognized by T lymphocytes that are isolated from bronchoalveolar lavage fluid of lung allograft recipients during periods of acute rejection. Methods: Lymphocytes isolated from 45 bronchoalveolar lavage samples (from 41 lung transplant recipients) served as effector cells in standard cell-mediated cytolytic assays with several cell lines as targets: BEAS-2B (an immortalized airway epithelial cell line); B-lymphoblastoid cell lines; and K562 (a natural killer-sensitive cell line), Cytotoxic T-lymphocyte activity of bronchoalveolar lavage lymphocytes was correlated with pathologic status. Results: During acute rejection alone (ie, without concomitant cytomegalovirus infection), mean lysis of the airway epithelial target was significantly greater, compared with during no rejection, when these targets expressed donor-specific HLA class I antigens (P =.007). Lysis of donor class I-matched B-lymphoblastoid cell line targets during rejection was not significantly different from lysis during no-rejection periods (P =.18). Mean lysis of K562, a natural killer cell target, did not differ between acute rejection (without concomitant cytomegalovirus infection) and no rejection (P =.30), During cytomegalovirus infection (without concomitant acute rejection), there was no difference in mean lysis of airway epithelial cells, B-lymphoblastoid cell lines, or K562 targets compared with during no cytomegalovirus infection, whereas during acute rejection, compared with cytomegalovirus infection without rejection, there was a significant increase in mean lysis of the airway epithelial target when it expressed donor-specific HLA antigens (P =.01). Conclusions: Donor HLA class I-specific cytotoxic T-lymphocyte activity directed at airway epithelial cells was demonstrated in bronchoalveolar lavage lymphocytes from lung transplant recipients, Lysis of these targets was significantly higher during episodes of acute rejection.
引用
收藏
页码:565 / 571
页数:7
相关论文
共 4 条
  • [1] DIFFERENTIATION OF CLASS-I-DIRECTED AND CLASS-II-DIRECTED DONOR-SPECIFIC ALLOREACTIVITY IN BRONCHOALVEOLAR LAVAGE LYMPHOCYTES FROM LUNG-TRANSPLANT RECIPIENTS
    REINSMOEN, NL
    BOLMAN, RM
    SAVIK, K
    BUTTERS, K
    HERTZ, M
    TRANSPLANTATION, 1992, 53 (01) : 181 - 189
  • [2] Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens
    van Kampen, CA
    Maarschalk, MFJVV
    Roelen, DL
    ten Berge, IJM
    Claas, FHJ
    TRANSPLANTATION, 2001, 71 (07) : 869 - 874
  • [3] Donor-specific cytotoxic lymphocyte activity from bronchoalveolar lavage during acute canine lung allograft rejection
    Sekine, Y
    Fujisawa, T
    Saitoh, Y
    Takeda, T
    Yoshida, S
    Urabe, N
    Baba, M
    Yamaguchi, Y
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 (05) : 902 - 909
  • [4] Soluble donor HLA class I and β2m-free heavy chain in serum of lung transplant recipients:: Steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome
    De Vito-Haynes, LD
    Jankowska-Gan, E
    Meyer, KC
    Cornwell, RD
    Zeevi, A
    Griffith, B
    Dauber, J
    Iacono, A
    Burlingham, WJ
    Love, RB
    HUMAN IMMUNOLOGY, 2000, 61 (12) : 1370 - 1382